113 related articles for article (PubMed ID: 38643159)
1. Epidemiological characteristics of asthma-COPD overlap, its association with all-cause mortality, and the mediating role of depressive symptoms: evidence from NHANES 2005-2018.
Zhu M; Chen A
BMC Public Health; 2024 May; 24(1):1423. PubMed ID: 38807148
[TBL] [Abstract][Full Text] [Related]
2. Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma-COPD (ACO) model.
João JMLG; Silva Barbosa JA; Sales da Silva LL; Fukuzaki S; de Campos EC; Camargo LDN; Dos Santos TM; Moreira Bezerra SK; de Almeida FM; Saraiva-Romanholo BM; Lopes FDTQDS; Bonturi CR; Righetti RF; Oliva MLV; Tibério IFLC; Leick EA
Front Pharmacol; 2024; 15():1282870. PubMed ID: 38774212
[TBL] [Abstract][Full Text] [Related]
3. Impaired PPARγ activation by cadmium exacerbates infection-induced lung injury.
Larson-Casey JL; Liu S; Pyles JM; Lapi SE; Saleem K; Antony VB; Gonzalez ML; Crossman DK; Carter AB
JCI Insight; 2023 May; 8(9):. PubMed ID: 36928191
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein AZGP1 inhibits epithelial cell proliferation by regulating the genes of alternative splicing in COPD.
Shen W; Wei W; Wang S; Yang X; Wang R; Tian H
Gene; 2024 Jun; ():148736. PubMed ID: 38950687
[TBL] [Abstract][Full Text] [Related]
5. A Multi-omic Analysis of the Human Lung Reveals Distinct Cell Specific Aging and Senescence Molecular Programs.
De Man R; McDonough JE; Adams TS; Manning EP; Myers G; Vos R; Ceulemans L; Dupont L; Vanaudenaerde BM; Wuyts WA; Rosas IO; Hagood JS; Ambalavanan N; Niklason L; Hansen KC; Yan X; Kaminski N
bioRxiv; 2023 Apr; ():. PubMed ID: 37131739
[TBL] [Abstract][Full Text] [Related]
6. What Single Cell RNA Sequencing Has Taught Us about Chronic Obstructive Pulmonary Disease.
Sin DD
Tuberc Respir Dis (Seoul); 2024 Jul; 87(3):252-260. PubMed ID: 38369875
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of asthma-chronic obstructive pulmonary disease overlap (ACO).
Uchida A; Sakaue K; Inoue H
Allergol Int; 2018 Apr; 67(2):165-171. PubMed ID: 29551279
[TBL] [Abstract][Full Text] [Related]
8. Update on Asthma-COPD Overlap (ACO): A Narrative Review.
Mekov E; Nuñez A; Sin DD; Ichinose M; Rhee CK; Maselli DJ; Coté A; Suppli Ulrik C; Maltais F; Anzueto A; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2021; 16():1783-1799. PubMed ID: 34168440
[TBL] [Abstract][Full Text] [Related]
9. PPARγ attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap.
Wan R; Srikaram P; Xie S; Chen Q; Hu C; Wan M; Li Y; Gao P
Respir Res; 2024 Apr; 25(1):174. PubMed ID: 38643159
[TBL] [Abstract][Full Text] [Related]
10. PPARγ Attenuates Cellular Senescence of Alveolar Macrophages in Asthma- COPD Overlap.
Wan R; Srikaram P; Xie S; Chen Q; Hu C; Wan M; Li Y; Gao P
Res Sq; 2024 Mar; ():. PubMed ID: 38496493
[TBL] [Abstract][Full Text] [Related]
11. Modulating asthma-COPD overlap responses with IL-17 inhibition.
Camargo LDN; Righetti RF; de Almeida FM; Dos Santos TM; Fukuzaki S; Martins NAB; Barbeiro MC; Saraiva-Romanholo BM; Lopes FDTQDS; Leick EA; Prado CM; Tibério IFLC
Front Immunol; 2023; 14():1271342. PubMed ID: 37965351
[TBL] [Abstract][Full Text] [Related]
12. β-Agonist exposure preferentially impacts lung macrophage cyclic AMP-related gene expression in asthma and asthma COPD overlap syndrome.
Moghbeli K; Valenzi E; Naramore R; Sembrat JC; Chen K; Rojas MM; Wenzel SE; Lafyatis R; Modena B; Weathington NM
Am J Physiol Lung Cell Mol Physiol; 2021 Nov; 321(5):L837-L843. PubMed ID: 34494468
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Effects of a New Peptide, Derived from the
Barbosa JAS; da Silva LLS; João JMLG; de Campos EC; Fukuzaki S; Camargo LDN; Dos Santos TM; Dos Santos HT; Bezerra SKM; Saraiva-Romanholo BM; Lopes FDTQDS; Bonturi CR; Oliva MLV; Leick EA; Righetti RF; Tibério IFLC
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834157
[TBL] [Abstract][Full Text] [Related]
14. Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study.
Dey S; Lu W; Haug G; Chia C; Larby J; Weber HC; Gaikwad AV; Bhattarai P; Shahzad AM; Pathinayake PS; Wark PAB; Eapen MS; Sohal SS
Respir Res; 2023 Sep; 24(1):221. PubMed ID: 37700291
[TBL] [Abstract][Full Text] [Related]
15. PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells.
Chen Z; Ghavimi SAA; Wu M; McNamara J; Barreiro O; Maridas D; Kratchmarov R; Siegel A; Djeddi S; Gutierrez-Arcelus M; Brennan PJ; Padera TP; von Andrian U; Mehrara B; Greene AK; Kahn CR; Orgill DP; Sinha I; Rosen V; Agarwal S
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 38131378
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
